PLAT and stroke disorder: Since the publication of the landmark NINDS trial (11) of tissue plasminogen activator (tPA) effect on acute ischemic stroke, IV thrombolysis in select acute ischemic strokes has become a standard of care, and it is considered a crucial treatment that can improve the long-term functional outcome in stroke (1).